How Doctors Test for Internal Shingles

Diagnosing internal shingles usually starts with a polymerase chain reaction (PCR) test, which detects the DNA of varicella-zoster virus (VZV) in body fluids such as blood, saliva, or cerebrospinal fluid. The challenge is that internal shingles often produces no rash at all, stripping doctors of the visual clue they normally rely on for a shingles diagnosis. That makes the testing process more involved, more dependent on suspicion than on obvious signs, and more reliant on laboratory confirmation than a standard shingles case.

Why Internal Shingles Is Harder to Catch

In a typical shingles case, a painful blistering rash appears along a strip of skin on one side of the body. Most doctors can recognize it on sight. Internal shingles, sometimes called zoster sine herpete (ZSH), is a variant where the virus reactivates in cranial nerves, spinal nerves, or organs but produces no skin blisters. Patients feel the pain, but there is nothing visible to point a doctor toward the right diagnosis.¹ The absence of that telltale rash means traditional diagnostic shortcuts fall apart, and doctors have to lean on lab work and imaging instead.²

Before any rash appears, shingles typically starts with nerve pain: sharp, burning, or prickling sensations in a band-like pattern. That pre-rash pain phase lasts anywhere from two days to two weeks. In those early days, patients are routinely misdiagnosed with conditions that mimic localized pain in the same area, including migraine, heart attack, pleurisy, gallstones, appendicitis, and stomach ulcers, depending on which nerve is involved.² In internal shingles, the rash may never arrive, so that window of misdiagnosis can stretch indefinitely unless a clinician thinks to test for VZV.

PCR Testing on Body Fluids

PCR is the workhorse of internal shingles diagnosis. It amplifies tiny traces of VZV DNA so the virus can be detected even when it is not producing visible skin lesions. When compared head-to-head against older methods like viral culture and direct fluorescent-antibody staining, PCR comes out far ahead: one study found PCR sensitivity reached 97.6 to 100 percent, compared with roughly 46 percent for culture and 88 percent for fluorescent-antibody staining.³ For specimens other than skin swabs, such as blood, cerebrospinal fluid, or eye fluid, nucleic acid detection is often the only reliable option.⁴

Which fluid gets tested depends on where the virus seems to be active. If neurological symptoms suggest the brain or spinal cord is involved, a spinal tap collects cerebrospinal fluid for PCR. If the patient has unexplained abdominal pain or gastrointestinal symptoms, a tissue biopsy from the gut lining can be tested. If the clinical picture is ambiguous, blood or saliva samples offer a less invasive starting point.

Saliva as a Surprisingly Useful Sample

One of the more practical developments in VZV testing is the discovery that the virus sheds into saliva during active infection. A study of shingles patients found VZV DNA in the saliva of all 17 patients tested before they started antiviral treatment. After several days of antiviral therapy, the virus was no longer detectable in any of them.⁵ The collection method mattered: passive drool produced about three times more viral DNA than a synthetic swab and about nine times more than a cotton swab.⁵

Saliva testing has shown particular promise for internal shingles cases where no rash is present. In a study that specifically looked at gut-related VZV, salivary VZV DNA was found in both patients with confirmed zoster sine herpete, and in more than half of patients with unexplained abdominal pain that turned out to be VZV-related. None of the healthy controls tested positive. After recovery, the viral DNA disappeared from saliva in every patient retested.⁶ This makes saliva a useful screening tool: it is painless to collect, does not require a hospital procedure, and the viral signal clears when the infection resolves, so a positive result reflects active disease rather than old exposure.

For suspected VZV meningoencephalitis, saliva PCR also showed encouraging results. In a preliminary study, VZV DNA appeared in the saliva of four out of five patients with confirmed VZV brain infection, while it was absent in patients with meningitis caused by other viruses.⁷ Saliva testing alone is not yet definitive enough to replace cerebrospinal fluid analysis in serious neurological cases, but it can flag the need for further investigation without a spinal tap.

Cerebrospinal Fluid Analysis for Brain and Spinal Cord Involvement

When VZV attacks the central nervous system, causing meningitis, encephalitis, or vasculopathy (inflammation of blood vessels in the brain), cerebrospinal fluid collected through a lumbar puncture becomes the key diagnostic specimen. Typical findings include elevated protein, an increase in white blood cells, and a positive PCR result for VZV DNA.⁸

Timing matters for which test works best on cerebrospinal fluid. PCR tends to pick up VZV DNA mainly within the first week after symptoms start. After that window, antibody testing becomes more useful: the immune system begins producing VZV-specific antibodies inside the central nervous system, and these can be detected even when the viral DNA itself has already been cleared. In one study of 34 patients, PCR was positive in 44 percent of cases overall, mostly within the first seven days, while antibody production showed up later, after the seven-day mark.⁹ In practice, this means a negative PCR result on cerebrospinal fluid does not rule out VZV, especially if the sample was collected more than a week into the illness. Running both PCR and antibody tests at the right time improves the chances of catching the virus.

VZV vasculopathy deserves special attention because it can cause stroke weeks or even months after a shingles episode, sometimes without any rash ever having appeared. The best virological test in this scenario is detecting anti-VZV antibodies in the cerebrospinal fluid rather than relying on PCR, since the viral DNA may have cleared by the time the stroke occurs.¹⁰

Imaging and What It Can Reveal

MRI does not detect the virus itself, but it can show the damage VZV causes to nerves and the spinal cord, which helps build the diagnostic case. In cases of VZV vasculopathy involving the brain, MRI commonly shows lesions that sit deep in the brain tissue, particularly at the junctions between gray and white matter, and these lesions may light up with contrast dye.¹⁰

When VZV attacks nerve roots along the spine, MRI can show inflammation and swelling of the affected nerve root and the dorsal root ganglion, the cluster of nerve cell bodies just outside the spinal cord. In one case, MRI revealed abnormal enhancement and increased signal in the affected lumbar nerve root, confirming active neuritis. The authors noted that even when there is no rash, VZV should be considered in the differential diagnosis whenever MRI shows acute inflammation of a spinal nerve.¹¹ In more extreme cases, MRI has revealed extensive spinal cord lesions stretching far beyond the area where the rash and weakness appeared, suggesting VZV can cause widespread inflammation even when symptoms are localized.¹²

MRI findings alone are not specific enough to confirm VZV. Nerve inflammation on MRI looks similar whether it is caused by VZV, another virus, or an autoimmune process. But combined with a clinical history of dermatomal pain and positive lab results, MRI helps doctors understand the extent of the damage and guide treatment decisions.

Tissue Biopsy for Gastrointestinal Cases

When VZV spreads to the digestive tract, the symptoms can look like many common GI conditions: abdominal pain, nausea, or bleeding. Endoscopy followed by tissue biopsy is one way to pin down the cause. In a case involving an otherwise healthy patient with stomach erosions, VZV was confirmed through PCR testing on a biopsy specimen taken from the gastric lining during endoscopy.¹³

Under the microscope, VZV creates distinctive patterns of injury in the GI tract that differ from herpes simplex virus, which can cause similar-looking ulcers. VZV tends to produce hemorrhagic ulcers with fibrin-rich exudates and involves deeper layers of tissue, including the stomach’s deep glands with striking cell death. Herpes simplex, by contrast, tends to cause shallower, rounder ulcers with different inflammatory patterns and affects the superficial layers of the lining.¹⁴ A pathologist who knows these differences can sometimes make the diagnosis from the tissue appearance alone, though PCR on the biopsy specimen provides definitive confirmation.

Skin Scraping PCR When the Rash Is Absent

This may sound paradoxical: scraping skin that looks normal to test for a skin virus. But a case report demonstrated that PCR performed on scrapings of intact, unblistered skin from the painful area successfully detected VZV DNA in a patient with zoster sine herpete. The virus was present in the skin even though no vesicles had formed.¹⁵ This technique is not yet widely used, but it offers a possible confirmation route when a patient has classic dermatomal pain and no rash, and other sample types are inconclusive.

Advanced Approaches for Difficult Cases

When standard PCR comes back negative but clinical suspicion remains high, a few less common methods can help. Metagenomic next-generation sequencing (mNGS) is an unbiased approach that sequences all of the DNA in a sample rather than looking for one specific virus. In a case involving an HIV-positive patient with a rapidly worsening brain infection, standard tests had not produced a clear answer, but mNGS on cerebrospinal fluid identified over 97,000 sequence reads mapping to VZV, covering nearly the entire viral genome. The finding was then confirmed by conventional PCR.¹⁶ This kind of sequencing is expensive and not yet routine, but it can be a lifesaver when doctors are running out of diagnostic options.

Another frontier involves metabolite profiling of cerebrospinal fluid. Researchers have identified specific small molecules whose concentrations differ between VZV meningoencephalitis, facial nerve zoster, and uninfected controls. In one study, a small panel of metabolites accurately distinguished VZV brain infection from other conditions, and some of these markers reflected specific disease processes rather than just general inflammation.¹⁷ This research is still in early stages, but it suggests future diagnostic panels could help catch VZV involvement that current tests miss.

Which Organs Internal Shingles Can Affect

The virus does not attack organs randomly. VZV reactivates in nerve clusters (ganglia) and then follows those nerve pathways, so the organ systems it disrupts depend on which nerves are involved. The most commonly affected internal functions are bladder and bowel control. When VZV reactivates in the sacral nerve roots, particularly S2 through S4, it can interrupt the nerve signals that control the bladder’s ability to contract, leading to urinary retention. Gastrointestinal dysfunction, including abdominal bloating and constipation from impaired sphincter control, is rarer but well documented.¹⁸

A review of 45 studies on VZV and autonomic nerve function found that bladder and bowel problems were by far the most frequently reported complications, reflecting localized nerve damage near the spinal cord. Cardiovascular dysfunction such as drops in blood pressure upon standing was rare and involved more widespread nerve damage.¹⁹ When doctors see unexplained urinary retention or sudden constipation along a nerve-distribution pattern, especially in a patient with pain but no rash, VZV testing can uncover the cause.

Why Speed Matters

Antiviral medications for shingles work best when started within 72 hours of symptom onset. In standard shingles, the rash provides a visible starting gun. With internal shingles, the clock is ticking before anyone realizes what they are dealing with. Oral antivirals reduce pain duration and help the skin heal faster when started promptly, and in patients with weakened immune systems, any signs of the virus spreading internally are a trigger to switch from oral to intravenous antiviral therapy.²

A scoping review of 156 cases of disseminated VZV with organ involvement found that early diagnosis was achieved in about two-thirds of patients and was significantly associated with survival.²⁰ That finding underscores a blunt reality: the patients who do best are the ones whose doctors considered VZV early enough to test for it and start treatment before the infection spiraled.

This is why clinicians sometimes begin antiviral treatment on suspicion alone, before lab results return, especially in immunocompromised patients or older adults with sudden unexplained nerve pain in a dermatomal pattern. Waiting for a definitive lab result can mean losing the treatment window. The test confirms what happened; the treatment decision often has to come first.

When Doctors Should Suspect VZV Without a Rash

Certain clinical patterns should raise a red flag. Unexplained pain that follows a single nerve distribution, especially in someone over 50 or with a compromised immune system, is the classic scenario. But internal shingles can also present as sudden urinary retention, new-onset facial paralysis, unexplained abdominal pain, or even a stroke in a younger patient with no cardiovascular risk factors. The virus can inflame cerebral arteries weeks or months after a shingles episode, and sometimes no rash ever appears.¹⁰

People with weakened immune systems from HIV, organ transplants, chemotherapy, or long-term immunosuppressive medications face the highest risk of internal or disseminated VZV. In these patients, the virus is more likely to spread beyond a single nerve dermatome and involve multiple organs. Standard skin-based diagnostic methods such as direct fluorescent-antibody staining and culture become less useful in these cases because they depend on catching a skin lesion at its earliest stage. Nucleic acid testing, particularly PCR, works at any stage of the lesion and is also the best or only option for testing non-skin specimens like blood and cerebrospinal fluid.⁴

The Practical Sequence of Testing

In practice, the diagnostic workup for suspected internal shingles tends to follow a rough sequence driven by how sick the patient is and what symptoms they have. For someone with dermatomal pain but no rash and no alarming neurological or organ symptoms, the first step is usually a blood draw for VZV PCR or VZV antibody levels, or a saliva sample if that testing is available locally. If those return positive and the clinical picture fits, the diagnosis is made.

For patients with neurological symptoms like severe headache, confusion, facial weakness, or limb weakness, the workup escalates quickly. A lumbar puncture is performed and the cerebrospinal fluid is sent for VZV PCR, antibody testing, cell count, and protein measurement. MRI of the brain or spine is ordered to assess the extent of involvement. For patients with GI symptoms that resist other explanations, endoscopy with biopsy may be the route to diagnosis, with PCR run on the tissue specimen.

Throughout this process, the clinician is also ruling out the mimics. Dermatomal chest pain that could be a heart attack gets an ECG and cardiac enzymes. Abdominal pain gets standard imaging. The VZV testing runs in parallel with these workups, and sometimes it is only after the usual suspects have been eliminated that VZV emerges as the answer. Keeping VZV on the differential diagnosis from the start, rather than arriving at it by exclusion, is what makes the difference between early and late diagnosis.